Evidence map›Paper›PMID 26071118›Full record

ReviewTrends in pharmacological sciences2015

The role of H2S bioavailability in endothelial dysfunction.

Rui Wang, Csaba Szabo, Fumito Ichinose, Asif Ahmed, Matthew Whiteman, Andreas Papapetropoulos

Open access · greenAbstract readReview
In one paragraph

Review in Trends in pharmacological sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
11.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 159 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Naturally Occurring HHandbook of experimental pharmacology · 2026
    Review
  5. Article
  6. Article
  7. Cystathionine γ lyase deletion enhances corpus cavernosum contraction via thromboxane AAmerican journal of physiology. Regulatory, integrative and comparative physiology · 2025
    Article
  8. The role of gasotransmitters in Parkinson's disease: Interplay of nitric oxide, carbon monoxide, and hydrogen sulfide.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  9. Role of cystathionine-β-synthase and hydrogen sulfide in down syndrome.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  10. Homocysteine Attack on Vascular Endothelium-Old and New Features.International journal of molecular sciences · 2025
    Review
  11. Article
  12. The Relevance of the Endothelium in Cardiopulmonary Disorders.International journal of molecular sciences · 2024
    Review
  13. Endothelial HRedox biology · 2024
    Article
  14. Using mechanism-based combinations of HNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Article
  15. Article
  16. Emerging Chemical Biology of Protein Persulfidation.Antioxidants & redox signaling · 2023
    Review
  17. Review
  18. Clinical Potential of Hydrogen Sulfide in Peripheral Arterial Disease.International journal of molecular sciences · 2023
    Review
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 4 countries.

Rui WangDepartment of Biology, Laurentian University, 935 Ramsey Lake Road, Sudbury, ON P3E 2C6, Canada. Electronic address: rui.wang@laurentian.ca.
Csaba SzaboDepartment of Anesthesiology, The University of Texas Medical Branch at Galveston, 601 Harborside Drive, Galveston, TX 77555, USA.
Fumito IchinoseDepartment of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Asif AhmedAston Medical Research Institute, Aston Medical School, Aston University, Aston Triangle, Birmingham B4 7ET, UK.
Matthew WhitemanUniversity of Exeter Medical School, St. Luke's Campus, Magdalen Road, Exeter EX1 2LU, UK.
Andreas PapapetropoulosFaculty of Pharmacy, University of Athens, Zografou Campus, Athens, 15771, Greece; George P. Livanos and Marianthi Simou Laboratories, First Department of Pulmonary and Critical Care Medicine, Evangelismos Hospital, Faculty of Medicine, University of Athens, Athens, 10675, Greece.
Aston University · GBLaurentian University · CAMassachusetts General Hospital · USNational and Kapodistrian University of Athens · GRThe University of Texas Medical Branch at Galveston · USUniversity of Exeter · GB

Funding

IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUSR01HL101930 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ICHINOSE, FUMITO · 2010 to 2014
$2.1M
Regulation of cellular bioenergetics by hydrogen sulfideR01GM107846 · NIGMS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SZABO, CSABA · 2014 to 2017
$1.2M
British Heart Foundation RG/09/001/25940Medical Research Council G0700288Medical Research Council G0701824Medical Research Council MR/L01985X/1Medical Research Council MR/M022706/1NHLBI NIH HHS R01 HL101930NIGMS NIH HHS R01 GM107846
6 · The paper itself

Abstract

Endothelial dysfunction (EDF) reflects pathophysiological changes in the phenotype and functions of endothelial cells that result from and/or contribute to a plethora of cardiovascular diseases. We review the role of hydrogen sulfide (H2S) in the pathogenesis of EDF, one of the fastest advancing research topics. Conventionally treated as an environment pollutant, H2S is also produced in endothelial cells and participates in the fine regulation of endothelial integrity and functions. Disturbed H2S bioavailability has been suggested to be a novel indicator of EDF progress and prognosis. EDF manifests in different forms in multiple pathologies, but therapeutics aimed at remedying altered H2S bioavailability may benefit all.

Indexed as

AnimalsEndothelium, VascularFree RadicalsHumansHydrogen SulfideVascular DiseasesFree RadicalsHydrogen Sulfidecystathionine gamma-lyaseendothelium-derived hyperpolarizing factorgasotransmittersheme oxygenase-1hydrogen sulfidenitric oxide

Identifiers

PMID26071118
PMCPMC4562801
OpenAlexW1590617898

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.